.
.
.
.
Coronavirus

EU regulator reviewing Moderna coronavirus shot for auto-immune blood condition

Published: Updated:

Europe’s drug regulator said on Wednesday it had assessed nine cases of an auto-immune blood condition following vaccination with Moderna Inc’s
COVID-19 shot, but no "clear causal relationship" could be established between the two.

The European Medicines Agency (EMA) said its safety committee would continue to monitor for cases of immune thrombocytopenia, an auto-immune condition with low blood platelet levels that can lead to bruising and bleeding, with Moderna’s vaccine, Spikevax.

For the latest headlines, follow our Google News channel online or via the app.

Read more: Will add warning about rare heart inflammation to Pfizer, Moderna vaccines, says FDA